Binding of SARS-CoV-2 protein ORF9b to mitochondrial translocase TOM70 prevents its interaction with chaperone HSP90

• Published in: Biochimie Vol. 200; pp. 99 - 106
• Main Authors: Ayinde, Kehinde S., Pinheiro, Glaucia M.S., Ramos, Carlos H.I.
• Format: Journal Article
• Language: English
• Published: France Elsevier B.V 01.09.2022; Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM)
• Subjects: Carrier Proteins - metabolism; COVID-19; Escherichia coli - metabolism; HSP90; HSP90 Heat-Shock Proteins - metabolism; Humans; Immune evasion; Mitochondrial Membrane Transport Proteins - metabolism; Mitochondrial Precursor Protein Import Complex Proteins; Pandemics; Protein Binding; Protein–protein interaction; SARS-CoV-2; TOM70; COVID-19; HSP90; SARS-CoV-2; Immune evasion; Protein–protein interaction; TOM70
• ISSN: 0300-9084; 1638-6183
• DOI: 10.1016/j.biochi.2022.05.016

The emergence of the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a great threat to global health. ORF9b, an important accessory protein of SARS-CoV-2, plays a critical role in the viral host interaction, targeting TOM70, a member of the mitochondrial translocase of the outer membrane complex. The assembly between ORF9b and TOM70 is implicated in disrupting mitochondrial antiviral signaling, leading to immune evasion. We describe the expression, purification, and characterization of ORF9b alone or coexpressed with the cytosolic domain of human TOM70 in E. coli. ORF9b has 97 residues and was purified as a homodimer with an molecular mass of 22 kDa as determined by SEC-MALS. Circular dichroism experiments showed that Orf9b alone exhibits a random conformation. The ORF9b-TOM70 complex characterized by CD and differential scanning calorimetry showed that the complex is folded and more thermally stable than free TOM70, indicating strong binding. Importantly, protein–protein interaction assays demonstrated that full-length human Hsp90 is capable of binding to free TOM70 but not to the ORF9b-TOM70 complex. To narrow down the nature of this inhibition, the isolated C-terminal domain of Hsp90 was also tested. These results were used to build a model of the mechanism of inhibition, in which ORF9b efficiently targets two sites of interaction between TOM70 and Hsp90. The findings showed that ORF9b complexed with TOM70 prevents the interaction with Hsp90, and this is one major explanation for SARS-CoV-2 evasion of host innate immunity via the inhibition of the interferon activation pathway. [Display omitted] •Free ORF9b was purified as a homodimer.•ORF9b binds TOM70 as a monomer.•ORF9b-TOM70 complex is folded and more thermally stable than free TOM70.•Binding of SARS-CoV-2 ORF9b to TOM70 prevents its interaction with HSP90.